Doxepin-Associated Hypoglycemia in an Ambulatory Nondiabetic Patient
Prim Care Companion CNS Disord. 2023 Jul 6;25(4):22cr03367. doi: 10.4088/PCC.22cr03367.NO ABSTRACTPMID:37419456 | DOI:10.4088/PCC.22cr03367 (Source: Primary Care)
Source: Primary Care - July 7, 2023 Category: Primary Care Authors: Hiba Z Hashmi Jasleen Kaur Steven C Stout Tyler Drake Source Type: research
Doxepin-Associated Hypoglycemia in an Ambulatory Nondiabetic Patient
Prim Care Companion CNS Disord. 2023 Jul 6;25(4):22cr03367. doi: 10.4088/PCC.22cr03367.NO ABSTRACTPMID:37419456 | DOI:10.4088/PCC.22cr03367 (Source: The Primary Care Companion for CNS Disorders)
Source: The Primary Care Companion for CNS Disorders - July 7, 2023 Category: Primary Care Authors: Hiba Z Hashmi Jasleen Kaur Steven C Stout Tyler Drake Source Type: research
Stigma and Efficacy of Zhizhu Kuanzhong Capsules Versus Doxepin in the Treatment of Refractory Functional Dyspepsia: A Randomized Controlled Trial
CONCLUSION: ZZKZ is superior to doxepin in alleviating stigma and medication non-adherence, with comparable efficacy in improving dyspeptic symptoms and psychological condition of patients with rFD.PMID:37417263 | DOI:10.5056/jnm22145 (Source: Journal of Neurogastroenterology and Motility)
Source: Journal of Neurogastroenterology and Motility - July 7, 2023 Category: Gastroenterology Authors: Qian-Qian Wang Li Cheng Bi-Yu Wu Hong-Yi Qiu Ping Xu Bo Wang Xiu-Juan Yan Sheng-Liang Chen Source Type: research
Doxepin-Associated Hypoglycemia in an Ambulatory Nondiabetic Patient
Prim Care Companion CNS Disord. 2023 Jul 6;25(4):22cr03367. doi: 10.4088/PCC.22cr03367.NO ABSTRACTPMID:37419456 | DOI:10.4088/PCC.22cr03367 (Source: The Primary Care Companion for CNS Disorders)
Source: The Primary Care Companion for CNS Disorders - July 7, 2023 Category: Primary Care Authors: Hiba Z Hashmi Jasleen Kaur Steven C Stout Tyler Drake Source Type: research
Stigma and Efficacy of Zhizhu Kuanzhong Capsules Versus Doxepin in the Treatment of Refractory Functional Dyspepsia: A Randomized Controlled Trial
CONCLUSION: ZZKZ is superior to doxepin in alleviating stigma and medication non-adherence, with comparable efficacy in improving dyspeptic symptoms and psychological condition of patients with rFD.PMID:37417263 | PMC:PMC10334204 | DOI:10.5056/jnm22145 (Source: Journal of Neurogastroenterology and Motility)
Source: Journal of Neurogastroenterology and Motility - July 7, 2023 Category: Gastroenterology Authors: Qian-Qian Wang Li Cheng Bi-Yu Wu Hong-Yi Qiu Ping Xu Bo Wang Xiu-Juan Yan Sheng-Liang Chen Source Type: research
Doxepin-Associated Hypoglycemia in an Ambulatory Nondiabetic Patient
Prim Care Companion CNS Disord. 2023 Jul 6;25(4):22cr03367. doi: 10.4088/PCC.22cr03367.NO ABSTRACTPMID:37419456 | DOI:10.4088/PCC.22cr03367 (Source: The Primary Care Companion for CNS Disorders)
Source: The Primary Care Companion for CNS Disorders - July 7, 2023 Category: Primary Care Authors: Hiba Z Hashmi Jasleen Kaur Steven C Stout Tyler Drake Source Type: research
Stigma and Efficacy of Zhizhu Kuanzhong Capsules Versus Doxepin in the Treatment of Refractory Functional Dyspepsia: A Randomized Controlled Trial
CONCLUSION: ZZKZ is superior to doxepin in alleviating stigma and medication non-adherence, with comparable efficacy in improving dyspeptic symptoms and psychological condition of patients with rFD.PMID:37417263 | PMC:PMC10334204 | DOI:10.5056/jnm22145 (Source: Journal of Neurogastroenterology and Motility)
Source: Journal of Neurogastroenterology and Motility - July 7, 2023 Category: Gastroenterology Authors: Qian-Qian Wang Li Cheng Bi-Yu Wu Hong-Yi Qiu Ping Xu Bo Wang Xiu-Juan Yan Sheng-Liang Chen Source Type: research
